Mirco Ponzoni
0000-0002-6164-4286
2 papers found
Refreshing results…
Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma
Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma
Missing publications? Search for publications with a matching author name.